Kyle Chang Selected Research

Kyle Chang Research Topics

Disease

14	Neoplasms (Cancer) 01/2024 - 11/2012
7	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2013
4	Carcinogenesis 03/2024 - 01/2017
3	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2021 - 01/2018
2	Adenoma (Adenomas) 01/2022 - 01/2017
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2019
2	Adenocarcinoma 01/2022 - 03/2021
2	Polyps 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2021 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 11/2012
1	Breast Neoplasms (Breast Cancer) 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	COVID-19 03/2021
1	Lung Neoplasms (Lung Cancer) 03/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Ulcerative Colitis 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2021
1	Residual Neoplasm 01/2021
1	Adenocarcinoma of Lung 01/2021
1	Lordosis 06/2019
1	Chronic Pancreatitis 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Turcot syndrome 01/2018
1	Microsatellite Instability 01/2013
1	Obesity 09/2011
1	Body Weight (Weight, Body) 09/2011
1	Stroke (Strokes) 09/2011
1	Bone Resorption 11/2005
1	Osteoporosis 04/2003

Drug/Important Bio-Agent (IBA)

4	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
4	CytokinesIBA 01/2021 - 11/2005
3	VaccinesIBA 01/2024 - 01/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2019
2	Sulindac (Copal)FDA LinkGeneric 01/2021 - 01/2017
1	Ado-Trastuzumab EmtansineIBA 04/2024
1	neratinibIBA 04/2024
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 03/2024
1	cyclopropapyrroloindoleIBA 01/2022
1	histone H3 trimethyl Lys4IBA 01/2022
1	HeterochromatinIBA 01/2022
1	Histones (Histone)IBA 01/2022
1	ChromatinIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 03/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Lipocalin-2IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	Naproxen (Naprosyn)FDA LinkGeneric 01/2021
1	Nucleic AcidsIBA 01/2021
1	EWS-FLI fusion proteinIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	Bexarotene (LGD1069)FDA Link 01/2021
1	Peptides (Polypeptides)IBA 01/2020
1	(+)-JQ1 compoundIBA 01/2019
1	sulforaphaneIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	CateninsIBA 01/2017
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2017
1	tolfenamic acidIBA 01/2017
1	SurvivinIBA 01/2017
1	Cyclin D1IBA 01/2017
1	Caspase 3 (Caspase-3)IBA 01/2017
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 01/2017
1	Calcibiotic Root Canal SealerIBA 01/2013
1	Insulin Receptor Substrate ProteinsIBA 09/2011
1	Glucose (Dextrose)FDA LinkGeneric 09/2011
1	Coloring Agents (Dyes)IBA 11/2005
1	Macrophage Colony-Stimulating FactorIBA 11/2005
1	Tartrate-Resistant Acid PhosphataseIBA 11/2005
1	ProstaglandinsIBA 04/2003
1	Prostaglandins EIBA 04/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 09/2011
2	Immunotherapy 01/2020 - 01/2018
1	Chemoprevention 01/2021
1	Aftercare (After-Treatment) 01/2019
1	Precision Medicine 01/2019
1	Ovariectomy (Oophorectomy) 04/2003